SEI Investments
LEGN icon

SEI Investments’s Legend Biotech LEGN Stock Holding History

SEI Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$673K Sell
23,318
-301,603
-93% -$8.14M ﹤0.01% 2513
2026
Q1 		$5.88M Buy
324,921
+221,899
+215% +$4.23M 0.01% 1442
2025
Q4 		$2.24M Buy
103,022
+45,199
+78% +$1.29M ﹤0.01% 1791
2025
Q3 		$1.89M Buy
57,823
+13,831
+31% +$511K ﹤0.01% 1717
2025
Q2 		$1.56M Sell
43,992
-24,036
-35% -$779K ﹤0.01% 1746
2025
Q1 		$2.31M Buy
68,028
+1,173
+2% +$42.1K ﹤0.01% 1583
2024
Q4 		$2.18M Buy
66,855
+15,058
+29% +$624K ﹤0.01% 1648
2024
Q3 		$2.52M Buy
51,797
+5,305
+11% +$283K ﹤0.01% 1575
2024
Q2 		$2.06M Buy
46,492
+702
+2% +$32.4K ﹤0.01% 1625
2024
Q1 		$2.57M Sell
45,790
-1,816
-4% -$110K ﹤0.01% 1511
2023
Q4 		$2.86M Sell
47,606
-26,637
-36% -$1.69M ﹤0.01% 1441
2023
Q3 		$4.99M Buy
74,243
+6,033
+9% +$419K 0.01% 1166
2023
Q2 		$4.71M Buy
68,210
+21,188
+45% +$1.38M 0.01% 1224
2023
Q1 		$2.27M Sell
47,022
-7,231
-13% -$354K ﹤0.01% 1564
2022
Q4 		$2.71M Buy
54,253
+2,288
+4% +$111K 0.01% 1333
2022
Q3 		$2.12M Buy
51,965
+19,115
+58% +$897K ﹤0.01% 1512
2022
Q2 		$1.81M Sell
32,850
-2,885
-8% -$122K ﹤0.01% 1605
2022
Q1 		$1.3M Buy
35,735
+11,710
+49% +$463K ﹤0.01% 1721
2021
Q4 		$1.12M Buy
24,025
+9,872
+70% +$501K ﹤0.01% 1800
2021
Q3 		$716K Buy
14,153
+581
+4% +$24.2K ﹤0.01% 1911
2021
Q2 		$557K Buy
+13,572
New +$461K ﹤0.01% 2028

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

SEI Investments's LEGN Position: Q2 2026 in Review

SEI Investments reduced its Legend Biotech (LEGN) stake by 93% in Q2 2026, selling an estimated $8.14M and leaving 23,318 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

SEI Investments first reported a position in LEGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $5.88M in Q1 2026. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • SEI Investments held 23,318 shares of Legend Biotech worth $673K as of Q2 2026.
  • SEI Investments sold 301,603 Legend Biotech shares in Q2 2026, an estimated $8.14M.
  • Legend Biotech made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2513 holding.
  • SEI Investments first reported a position in Legend Biotech in Q2 2021 and has held it in 21 quarters since.
  • SEI Investments's Legend Biotech position peaked at $5.88M in Q1 2026.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.